home > pill identifier and drug identification

Consumer

User Reviews & Ratings - gemcitabine intravenous


Read user comments about the side effects, benefits, and effectiveness of gemcitabine intravenous.

Overall User Ratings

17 Total User Reviews

User Reviews

1-4 of 4
Condition: Cancer of the Ovary
8/19/2015 9:52:24 PM

Reviewer: hipgrandmapat, 65-74 Female on Treatment for less than 1 month (Patient)

Effectiveness

Current Rating: 5

Ease of Use

Current Rating: 5

Satisfaction

Current Rating: 5

Comment:
Just started treatment so too early to say

Condition: Cancer of the Ovary
2/28/2009 9:55:46 PM

Reviewer: Male (Caregiver)

Effectiveness

Current Rating: 4

Ease of Use

Current Rating: 2

Satisfaction

Current Rating: 3

Comment:
Worked when Doxil failed. It halted the progression of my grandmother's platinum resistant disease.

Condition: Cancer of the Ovary
8/5/2008 7:04:46 PM

Reviewer: 45-54 Female on Treatment for 1 to 6 months (Patient)

Effectiveness

Current Rating: 3

Ease of Use

Current Rating: 5

Satisfaction

Current Rating: 3

Comment:
I have recurrent ovarian cancer with disease in 5 regions of lymph nodes. The only side effect I had was low red/white cell counts and low platelets. Gemcitabine/Carboplatin worked extremely well for about 4 months (CA125 from 465 to 20, one area of cancer on PET/CT gone, all others shrunk), but then it just stopped having an effect. CA125 is rising again and I'm starting on a different dru ... Show Full Comment

Condition: Cancer of the Ovary
6/18/2008 1:10:46 PM

Reviewer: on Treatment for 1 to 6 months (Caregiver)

Effectiveness

Current Rating: 1

Ease of Use

Current Rating: 4

Satisfaction

Current Rating: 1

Comment:
My mother was on this drug for ovarian cancer and she developed a irregular heart beat from this dryg which caused her to throw a blood clot and have a stroke and die.

1-4 of 4

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.